The ZEBRA study: Early benefits in quality of life in goserelin-treated vs CMF-treated pre-/perimenopausal patients with node-positive early breast cancer
- 30 September 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: